Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN11668233
ISRCTN11668233
Active, not recruiting
未知

A non-interventional, mixed-methods, prospective cohort study to characterise the real-world implementation, roll out, safety and patient experience of the long-acting injectable HIV treatment regimen of 2-monthly cabotegravir and rilpivirine

niversity of Sussex0 sites200 target enrollmentFebruary 7, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPeople living with HIV on injectable antiretroviral treatment (CAB+RPV)Infections and Infestations

Overview

Phase
未知
Intervention
Not specified
Conditions
People living with HIV on injectable antiretroviral treatment (CAB+RPV)
Sponsor
niversity of Sussex
Enrollment
200
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2024
End Date
April 30, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Sussex

Eligibility Criteria

Inclusion Criteria

  • •1\. Understand the participant information and the study requirements and has the capacity to consent
  • •2\. Willing to comply with study procedures
  • •3\. Age 16 years or above
  • •4\. Is a member of one of the following groups:
  • •4\.1\. LA group \- PLWH who have been recently switched (within the prior 6 months) or are prospectively switched to LA CAB\+RPV during the enrolment period. This includes those who have received LA CAB\+RPV outside of BHIVA criteria or on compassionate grounds.
  • •4\.2\. Oral ART group \- PLWH who are demographically similar but not eligible for LA CAB\+RPV according to BHIVA eligibility criteria and who continue oral ART within the study period (e.g. those who are HBVcoreAb\+ or who have an underlying drug resistance mutation that precludes use of LA CAB\+RPV). The intervention group to the oral group will be matched 3:1 by calendar period and other key variables where possible.

Exclusion Criteria

  • •1\. In the opinion of the investigator is unable or unwilling to comply with the study requirements
  • •2\. Aged \< 16 years old

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Impact of mental health and stress on Physical Recovery of Patients after Total Joint Replacement
CTRI/2022/03/041238Self funded Mrs Shilpi Singh
Not yet recruiting
Not Applicable
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritis
DRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
Completed
Not Applicable
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiency
DRKS00015079CSL Behring GmbH73
Active, not recruiting
Not Applicable
Observational study of a motion capture device (AKIRA) in patients with ALS
JPRN-jRCT1030230648Hirai Manabu35
Active, not recruiting
Not Applicable
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disorders
ACTRN12610000558022Ipsen Pty Ltd70